Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

PPhathom Pharmaceuticals, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
P

Phathom Pharmaceuticals, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $74.27M. Net result −$17.58M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $74.27M. Running result $74.27M. Revenue: $74.27M.
  • Cost of revenue: −$15.1M. Running result $59.18M.
  • Gross profit: $59.18M. Running result $59.18M.
  • Research and development: −$7.81M. Running result $51.37M.
  • Selling, general and administrative: −$55.33M. Running result −$3.97M.
  • Operating income: −$3.97M. Running result −$3.97M.
  • Other expense: −$13.62M. Running result −$17.58M.
  • Pre-tax loss: −$17.58M. Running result −$17.58M.
  • Income tax benefit: $0. Running result −$17.58M.
  • Net loss: −$17.58M. Running result −$17.58M.